Device Trial Radar · NCT01368744
Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology
Last checked: Nov 19, 2026Latest source record: Jun 8, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Planned (sponsor's estimate)
Start
Mar 2010
Primary completion
Jun 2011
Study completion Jun 2011
Sponsor
- Lead sponsor
- Sysmex America, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 8, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to an extensive intraoperative frozen section protocol for Sentinel Lymph Nodes removed during standard Sentinel Lymph Node biopsy procedures from breast cancer subjects.
Conditions
- Breast Neoplasms
- Breast Diseases
Interventions
OSNA Breast Cancer SystemDevice
For in vitro diagnostic use only. The OSNA Breast Cancer System is an automated semi-quantitative, in vitro diagnostic test for the rapid detection of greater than (\>) 0.2 mm metastases in nodal tissue removed from sentinel lymph node biopsies of breast cancer patients. Results from the assay can be used to guide the intra-operative or post-operative decision to remove additional lymph nodes and to aid in patient staging. An assay positive + or ++ result indicates the presence of metastasis (\> 0.2 mm). An assay positive ++ result predicts the presence of macrometastasis (\> 2 mm). Groups: OSNA Breast Cancer System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prospectively assess the concordance and performance of the OSNA Breast Cancer System with an extensive intraoperative frozen section protocol for SLNs removed using standard SLN biopsy procedures from breast cancer subjects.Time frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Milan School of Medicine
Milan, Italy, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.